home / stock / soly / soly news

SOLY News and Press, Soliton Inc. From 01/13/20

Stock Information
Company Name: Soliton Inc.
Stock Symbol: SOLY
Market: NYSE
Website: soliton.com
Menu
SOLY SOLY Quote SOLY Short SOLY News SOLY Articles SOLY Message Board
Get SOLY Alerts

News, Short Squeeze, Breakout and More Instantly...
SOLY - Soliton To Announce Keloid and Hypertrophic Scar Clinical 12-Week Trial Data at Maui Derm Meeting

HOUSTON , Jan. 13, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...
SOLY - Soliton Appoints Robert "Joe" Mills as Vice President of Supply Chain

HOUSTON , Jan. 7, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today annou...

SOLY - Why the U.S. Remains the Largest Market for Medical Devices

December 18, 2019 Palm Beach, FL – December 18, 2019 – Back in the end of 2018, a report from Moody’s said that 2019 should be a standout year for the medical device industry. They added that revenue growth for device companies would be driven through innovation...

SOLY - Soliton Announces Successful Completion of Safety Testing at SGS to Support FDA Filing for Second Generation Device

HOUSTON , Dec. 18, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...
SOLY - Soliton Appoints Mary Stoll as Senior Director of Clinical Development

HOUSTON , Dec. 10, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...

SOLY - Soliton Initiates Significant Step Towards Commercialization

HOUSTON , Dec. 3, 2019 /PRNewswire/ -- Medical device innovation company Soliton, Inc. (Nasdaq: SOLY) today announced that it has engaged Tailfin, an Atlanta based brand and marketing firm, to help develop brand strategy and marketing and sales materials to help power the laun...

SOLY - Soliton and Emphysys Enter Into a 3-year Development Agreement

HOUSTON , Nov. 21, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced...
SOLY - Soliton Announces First Follow-up Visit Conducted in the Pivotal Cellulite Clinical Trial

HOUSTON , Nov. 12, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...

SOLY - Soliton holders file to offer 1M shares

Soliton (NASDAQ: SOLY ) is down 1.5% in light postmarket trading after a shareholder filing to offer shares . More news on: Soliton, Inc., Healthcare stocks news, Stocks on the move, Read more ...

SOLY - Soliton Completes Treatment of All Patients in Pivotal Cellulite Trial

HOUSTON , Nov. 5, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today...
Previous 10 Next 10